ReviewFrontiers in pharmacology2024

The impact of sarcopenia on the efficacy of PD-1 inhibitors in non-small cell lung cancer and potential strategies to overcome resistance.

Zhenchao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.